Fangzhou Launches Otsuka's Third-Generation Leukemia Drug Ponatinib on its Platform
GUANGZHOU, China, May 6, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced the availability of Otsuka Pharmaceutical's third-generation tyrosine kinase inhibitor (TKI)...
The World's Third-largest National Pension Service (NPS) to Support Proposals from Korea Zinc's Current Management at the EGM
SEOUL, South Korea, Jan. 20, 2025 /PRNewswire/ -- Korea Zinc has announced that the National Pension Service (NPS) has decided on its voting direction for Korea Zinc's Extraordinary General Meeting (EGM). As the world's third-largest pension fund...